EDIVROEditorial illustrationEDIVRO Editorial
news
Novartis reports European approval for Cosentyx in adult PMR
Novartis says the European Commission has approved Cosentyx for a defined group of adults with polymyalgia rheumatica.
Edivro Company News · Original attributed summary. Source announcement: 2026-10-21.